The term pharmaceutically acceptable organic group as used herein refers to those biologically acceptable organic groups which covalently bond to the organic grouping of Formula I [i.e., R--N(H)N(NO)O--] to form ethers, esters and other derivatives thereof [e.g., R--N(H)N(NO)O--X; wherein X is a biologically acceptable organic group].